Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barlier

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Pituitary|December 9, 2025
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predispositionCécilia Piazzola, Lauriane Le Collen, Théo Charnay, et al.
European Journal of Endocrinology|October 6, 2022
IGSF1 mutations are the most frequent genetic aetiology of thyrotropin deficiencyRachel Fourneaux, Rachel Reynaud, Gregory Mougel, et al.
Human Gene Therapy|September 28, 2011
Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cellsCatherine Roche, Ramahefarizo Rasolonjanahary, Sylvie Thirion, et al.
Molecular and Cellular Endocrinology|February 22, 2012
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretionThomas Cuny, Amira Mohamed, Thomas Graillon, et al.
Plos One|December 7, 2013
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomasAlessio Imperiale, François-Marie Moussallieh, Frédéric Sebag, et al.
Oncotarget|September 15, 2017
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma <i>in vitro</i>Thomas Graillon, David Romano, Céline Defilles, et al.
Journal of Neurosurgery|December 17, 2016
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature reviewThomas Graillon, David Romano, Céline Defilles, et al.
Journal of Neuro-Oncology|October 31, 2015
Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomasDavid Taïeb, Anne Barlier, Chunzhang Yang, et al.
European Journal of Human Genetics : EJHG|January 8, 2026
Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteriaRoseline Vibert, Yahya El Baroudi, Maude Vecten, et al.
International Journal of Cancer|May 22, 2007
Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatmentChristophe Picard, Monique Silvy, Corinne Gerard, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Pituitary|December 9, 2025
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predispositionCécilia Piazzola, Lauriane Le Collen, Théo Charnay, et al.
European Journal of Endocrinology|October 6, 2022
IGSF1 mutations are the most frequent genetic aetiology of thyrotropin deficiencyRachel Fourneaux, Rachel Reynaud, Gregory Mougel, et al.
Human Gene Therapy|September 28, 2011
Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cellsCatherine Roche, Ramahefarizo Rasolonjanahary, Sylvie Thirion, et al.
Molecular and Cellular Endocrinology|February 22, 2012
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretionThomas Cuny, Amira Mohamed, Thomas Graillon, et al.
Plos One|December 7, 2013
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomasAlessio Imperiale, François-Marie Moussallieh, Frédéric Sebag, et al.
Oncotarget|September 15, 2017
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma <i>in vitro</i>Thomas Graillon, David Romano, Céline Defilles, et al.
Journal of Neurosurgery|December 17, 2016
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature reviewThomas Graillon, David Romano, Céline Defilles, et al.
Journal of Neuro-Oncology|October 31, 2015
Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomasDavid Taïeb, Anne Barlier, Chunzhang Yang, et al.
European Journal of Human Genetics : EJHG|January 8, 2026
Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteriaRoseline Vibert, Yahya El Baroudi, Maude Vecten, et al.
International Journal of Cancer|May 22, 2007
Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatmentChristophe Picard, Monique Silvy, Corinne Gerard, et al.
Pageof 17